Munshi Amit (CIK 1612551) reported 4 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-06-09). Recent activity: Buy ARQT (5,778 shares), Sell IKT (19,089 shares), Buy ARQT (2,021 shares), Buy IKT (57,265 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-09 | Arcutis Biotherapeutics, Inc. (ARQT) | Director | Buy | 5,778 | $0 |
| 2026-02-24 | Inhibikase Therapeutics, Inc. (IKT) | Director | Sell | 19,089 | $0 |
| 2025-12-08 | Arcutis Biotherapeutics, Inc. (ARQT) | Director | Buy | 2,021 | $0 |
| 2025-08-28 | Inhibikase Therapeutics, Inc. (IKT) | Director | Buy | 57,265 | $0 |
Source: SEC Form 4 filings · as of 2026-06-09